Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer

Mark Scholz,1 Sabrina Yep,1 Micah Chancey,1 Colleen Kelly,1 Ken Chau,1 Jeffrey Turner,1 Richard Lam,1 Charles G Drake,2,3 1Prostate Oncology Specialists, Inc., Marina del Rey, CA, 2The Sidney Kimmel Cancer Center, 3The James Buchanan Brady Urological Institute, John Hopkins Medical Institutions, Bal...

Full description

Bibliographic Details
Main Authors: Scholz M, Yep S, Chancey M, Kelly C, Chau K, Turner J, Lam R, Drake CG
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:ImmunoTargets and Therapy
Subjects:
sipuleucel-T
ipilimumab
prostate cancer
immune therapy
Online Access:https://www.dovepress.com/phase-i-clinical-trial-of-sipuleucel-t-combined-with-escalating-doses--peer-reviewed-article-ITT

Internet

https://www.dovepress.com/phase-i-clinical-trial-of-sipuleucel-t-combined-with-escalating-doses--peer-reviewed-article-ITT

Similar Items